Overview

Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to compare the effectiveness of Human Regular U-500 Insulin three times a day versus twice a day.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Insulin
Insulin, Globin Zinc